Evaluating the efficacy of an SMS text message information and support programme for people who have experienced a motor vehicle-related injury: protocol for a double-blind randomised controlled trial Authors: Alison Sim, Ali Gholamrezaei, Claire Richardson, Claire E Ashton-James Published: 2026 ABSTRACT AbstractIntroductionRoad traffic injuries can be physically and emotionally challenging, and navigating compensation processes may increase uncertainty and distress. Early high distress is linked with poorer long-term recovery, including persistent pain and delayed return to work. Digital health tools, particularly brief, scalable SMS programmes, may offer timely information and emotional support during recovery. This protocol outlines a double-blind randomised controlled trial evaluating the efficacy, feasibility and acceptability of an SMS-delivered health information and support programme for people who have lodged a compulsory third party (CTP) insurance claim after a motor-vehicle-related injury.Methods and analysisThis double-blind, two-arm parallel-group trial will recruit 254 adults in New South Wales, Australia, who recently sustained a motor-vehicle-related injury and lodged a CTP claim with Allianz Insurance Australia (Allianz). Participants will be randomised (1:1) to either: (1) an intervention group receiving two co-designed informational videos plus 28 days of once-daily supportive SMS messages in addition to usual care, or (2) an active control group receiving the same videos and usual care only. The primary outcome is pain self-efficacy at 30 days, assessed using the Pain Self-Efficacy Questionnaire (PSEQ-10). Secondary outcomes include claimant satisfaction, pain and pain interference, anxiety and depression, pain-related concerns, perceived social support, healthcare costs and return-to-work status. Feasibility and acceptability will be assessed using the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation and Maintenance) through engagement data, reach, satisfaction ratings and qualitative interviews. Analyses will follow intention-to-treat principles with thematic analysis for qualitative data.Ethics and disseminationEthical approval has been granted by The University of Sydney Human Research Ethics Committee (2025/HE001079). Findings will be shared through publications, conference presentations and stakeholder reports to guide future digital support initiatives in compensation settings.Trial registration numberACTRN12625001043426.Keywords: Health informatics, Clinical Trial, Digital Technology, eHealth, REHABILITATION MEDICINE, Social Support STRENGTHS AND LIMITATIONS OF THIS STUDY This protocol describes a double-blind randomised controlled trial with participants, case managers, outcome assessors and statisticians blinded to group allocation. This protocol describes a double-blind randomised controlled trial with participants, case managers, outcome assessors and statisticians blinded to group allocation. The use of an active control group enables evaluation of the additional effect of SMS support while maintaining participant masking. The use of an active control group enables evaluation of the additional effect of SMS support while maintaining participant masking. Outcomes are measured using validated instruments assessing pain self-efficacy, pain, psychological distress and related recovery outcomes. Outcomes are measured using validated instruments assessing pain self-efficacy, pain, psychological distress and related recovery outcomes. The embedded qualitative study and RE-AIM framework (Reach, Effectiveness, Adoption, Implementation and Maintenance) will enable evaluation of intervention feasibility, acceptability and implementation considerations. The embedded qualitative study and RE-AIM framework (Reach, Effectiveness, Adoption, Implementation and Maintenance) will enable evaluation of intervention feasibility, acceptability and implementation considerations. All outcomes are self-reported and collected online, which may introduce response bias and limit participation among individuals with lower digital literacy. All outcomes are self-reported and collected online, which may introduce response bias and limit participation among individuals with lower digital literacy. Introduction Background and rationale Road traffic-related injuries can be highly distressing, not only due to physical trauma but also the complexities of navigating the compensation process.1–7 Individuals may experience shock, uncertainty and a sense of loss, and many find the claims process overwhelming.8–10 Research has shown that higher levels of distress following injury are associated with poorer recovery outcomes, including prolonged disability and higher risk of persistent pain.5–7 11 12 Distress in this context is characterised by feelings of being overwhelmed, low self-efficacy,13 high pain catastrophising14 and negative expectations about recovery. Beyond the physical injury itself, navigating the claims process can contribute to or exacerbate distress, particularly when individuals feel unsupported or uncertain about their entitlements and recovery trajectory.8 9 15 Opportunities to address distress and enhance claimant support may improve both psychological and functional recovery outcomes.16–18 Unmanaged distress following injury not only affects an individual’s psychological well-being but can also hinder recovery and prolong engagement with the compensation system.15 19 Higher levels of distress following road traffic-related injury are associated with increased disability, delayed return to work and greater healthcare utilisation,15 20 placing a significant burden on individuals, their families and society. Research by Grant et al has highlighted a strong relationship between claimants’ early distress, dissatisfaction with third-party insurers, more stressful compensation-related experiences and slower recovery.15 Addressing distress early in the claims process and providing appropriate support may help mitigate these negative outcomes, improving both claimant experiences and system efficiency.17 18 21–25 Research suggests that digital health support (eg, automated mobile messaging and automated telephone intervention) may be an effective way of supporting people in settings, including intensive care unit discharge,26 opioid tapering,27 28 recovery from breast cancer29 and recovery from injury.30 Digital health strategies offer cost-effective and scalable ways to provide information and support for participants, especially in situations where in-person support is limited.31 Our previous research using daily SMS text messaging to provide information and support to people with chronic non-cancer pain who are tapering from opioids was well received by patients.28 They described the educational content to be helpful and the delivery via text messages to be convenient and allowed for real-time prompting for self-management strategies. To ensure that the information and support provided in the SMS text messages and videos in this study meet the needs of the participant population, a co-design process was undertaken. Using qualitative methodology, we interviewed former claimants and staff of a single insurance agent (the insurer) to understand their experiences of the barriers and facilitators of a positive claims experience. This process directly informed the development of the video script and the SMS text messages. Objectives The primary objective of this trial is to evaluate the efficacy of a text message intervention to improve claimant pain self-efficacy (as measured by the Pain Self-Efficacy Questionnaire (PSEQ-10))32 following road traffic-related injury in a single insurance road traffic injury compensation setting. Secondary objectives are to (a) evaluate the efficacy of the intervention compared with active control in improving satisfaction with the claims process, reducing pain, reducing anxiety and depression, reducing concerns about pain, reducing healthcare costs and improving return to work times following road traffic related injury, (b) to evaluate the feasibility of the intervention using the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation and Maintenance), by examining participant engagement metrics, patterns of uptake and completion and perceptions of acceptability among claimants to inform future implementation and scale-up within insurer settings and (c) to evaluate the feasibility of the intervention by exploring participants’ experiences with the intervention, and suggestions for improvement using an embedded qualitative study. Methods and analysis This report is prepared according to the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT, online supplemental appendix A) checklist. Patient and public involvement The development of this SMS intervention was informed by extensive engagement with former claimants and insurer staff to ensure that it addressed the real-world experiences and needs of people navigating the motor vehicle injury claims process. Specifically, 11 former claimants and 10 current staff of the insurer participated in a co-design process led by the research team. These consultations explored claimants’ experiences of lodging and managing their claims, identified aspects of the claims journey that could be improved, and elicited suggestions for the types of information and support that would be most helpful in facilitating recovery and engagement with the process. The content of the SMS text messages and video scripts was developed directly from this co-design phase. Messages were drafted to address key areas of claimant concern such as uncertainty about key processes, practical tips about communication with claims staff and strategies to improve confidence in managing recovery. These were refined through iterative feedback from former claimants and insurer representatives. The research team then worked in partnership with the insurer to ensure that all messaging aligned with the insurer’s communication tone, values and legislative requirements. This collaborative process ensured that the digital support materials were accurate, consistent with policy and regulatory standards, and acceptable to both consumers and insurer stakeholders. Study design This study is a double-blind randomised controlled trial designed to test the primary hypothesis that receiving two educational videos followed by daily supportive text messages, in addition to usual customer service, will lead to greater improvements in pain self-efficacy than receiving the two educational videos and usual customer service alone. The trial targets individuals who have sustained a road traffic-related injury and lodged a compulsory third party (CTP) insurance claim with Allianz in New South Wales. Participants are randomised (1:1) to one of groups: (1) SMS support intervention plus informational videos or (2) active control with informational videos only. The study involves no placebo and uses digital intervention delivery methods without in-person treatment. There is no gold-standard ‘placebo’ control for digital health interventions and designing a sham or placebo is challenging in this field. Using an active control condition in the current study will allow us to achieve masking and investigate whether the observed effects can be attributed to a specific component of the digital support (ie, daily text messages).28 Importantly, the active control condition (ie, the informational videos) is likely to benefit participants. Informational videos to support recovery following injury have been shown to be acceptable and helpful to participants.16 33 Study setting Participants will be recruited from New South Wales, Australia, through the insurer. Recruitment will occur via insurer case managers during standard onboarding calls with new claimants who have recently lodged a CTP insurance claim following a motor vehicle-related injury. All data collection, management and analysis will be conducted by the research team at The University of Sydney. Participants, screening and recruitment procedures The insurer’s case managers will introduce the study to potential participants during their usual claims establishment conversations. To ensure a consistent approach, case managers will follow a scripted explanation that briefly describes the purpose of the study, the voluntary nature of participation and the process for referral (online supplemental appendix B). If a claimant expresses interest, they will be asked for permission to share their first name and mobile phone number with the research team. The University of Sydney research team will then send an SMS message (during working hours) containing a secure link to the online Participant Information Statement and Consent Form (PISCF; online supplemental appendix C). Once consent is obtained, the participants will automatically proceed to the baseline survey, which includes demographic questions and the first set of outcome measures. Eligibility criteria are confirmed as part of this initial screening process via self-report within the consent form (box 1). Eligibility criteria Inclusion criteria Aged ≥18 years. Aged ≥18 years. Lodged a compulsory third party insurance claim with the insurer following a road traffic-related injury. Lodged a compulsory third party insurance claim with the insurer following a road traffic-related injury. Owns a smartphone and can receive SMS text messages and access video links. Owns a smartphone and can receive SMS text messages and access video links. Able to read and understand English (or supported by a translator). Able to read and understand English (or supported by a translator). Willing and able to provide informed consent and complete digital surveys. Willing and able to provide informed consent and complete digital surveys. Exclusion criteria Cognitive impairment or language limitations that prevent survey completion. Cognitive impairment or language limitations that prevent survey completion. Inability to engage with digital content due to medical/mental health status (assessed via self-report to the researchers during the consent process or throughout the trial). Inability to engage with digital content due to medical/mental health status (assessed via self-report to the researchers during the consent process or throughout the trial). Interventions Usual customer care In this study, usual customer care is defined as any care and information that is provided to participants in the course of their normal claims processes. This might include contact with their claims manager and any services or treatment that may be facilitated as part of normal claims management. For some claimants, this might involve light facilitation of the claims process by the case manager. For other claimants, it may involve extensive contact with the claimant to facilitate the claims process, the provision of social support and assistance with accessing appropriate medical and allied health treatment from the claims management team. Intervention group After signing the consent form and completing baseline questionnaire, participants will be randomised (1:1) into two groups (figure 1). Study flow diagram. Study flow chart The intervention includes two informational videos about the claims process, followed by delivery of once daily supportive text messaging for 28 days, in addition to usual customer support. Claims information videos: participants will view two narrated and animated videos (4:53 and 5:52 min in duration) which have been co-designed with former claimants of the insurer as well as claims staff of the insurer. The videos will provide targeted information about the claims process. They will help claimants to feel informed about how to navigate the administrative processes associated with the claim and how to access additional support for specific needs during the recovery period. The first of these videos will be sent via a link in an SMS text message on day 0, together with an opt-out link. (online supplemental appendix D). The second video link will be sent on day 1. Supportive text messaging: participants in the intervention group will receive 1 supportive text message daily for a further 28 days to reinforce the information provided in the videos described above. The text messages are designed to remind claimants of the services and support that can be provided by the insurer during the recovery period and encourage them to take a pro-active approach to managing the claims process (see examples in box 2 and online supplemental appendix E). They are also aiming to provide messages of reassurance and support. Starting from day 2, participants will receive 1 text message daily for 28 days (30 messages in total including 2 with the claims management videos). Examples of SMS text messages Insurance navigation information Be sure to request approval from your case manager for treatment before you get started with a treatment provider. All you need is a referral for treatment from your GP [general practitioner]. Our claims team will review the request and check that it is reasonable and necessary for your recovery. We’ll let you know if it’s approved and then you can start treatment. Socioemotional support It’s normal to feel worried about pain, but remember, most people improve with time and activity. Staying active, even in small ways, helps your body heal and keeps you moving toward recovery. The messages sent to the participants are standardised in their content and delivery (by day of study). All text messages are short with a range of 17–397 characters and a mean of 166 characters. The language used is simple, with a mean Flesch-Kincaid Grade Level of 5.9 (year 6 reading level).34 Participants’ first names are used in a selection of messages to increase engagement (eg, ‘Hi John’). Messages will be sent over Australian telephone networks and an alpha-numeric ID (claimwise) will appear with the text message to indicate to participants who the text messages are from, increasing the trustworthiness of the source of the text. There will be no cost to individual participants. Participants will be informed in the first text message that the text messages are designed to be one-way and that responses to the text messages will not be monitored by the research team in real time. However, they can cease receiving text messages by completing the opt-out form, contained in a link in the first text (online supplemental appendix F) or by contacting the chief investigator (by email, as per the PISCF), who will give participants the option of withdrawing from the study if they wish. If withdrawing from the study, no further assessment will be sent to the participant. Participants will be informed in the first text message that they must not access their text messages while driving. Participants will be compensated for their time on completion of each survey to the value of $A10 via an electronic gift card (total of $A30 for completion of all three surveys).35 Control group (videos only) Participants in the active control group will receive the same videos delivered to participants in the intervention group. The active control group will not receive additional supportive text messages. However, they will receive text messages containing links to brief online surveys containing study outcome measures. Consequently, the intervention and active control groups will both expect and receive text messages. Both groups will receive usual support from their case managers and customer support at Allianz. Message delivery will be managed by MessageMedia (MessageMedia, Melbourne, Australia). Outcomes The evaluation of this intervention is structured using the RE-AIM framework,36 37 which provides a comprehensive approach to assessing both the efficacy and real-world applicability of digital health interventions. In line with this framework, the trial examines not only clinical and behavioural outcomes (effectiveness) but also the extent to which the programme reaches its intended population, the level of engagement and adoption among participants, the fidelity and acceptability of the intervention’s delivery, and indicators of potential maintenance and scalability within insurance-based injury recovery settings. Primary outcome The primary outcome in this study is pain self-efficacy, reflecting the intervention’s theoretical foundation in enhancing individuals’ confidence to manage pain and recovery after motor-vehicle injury. Assessed on day 0, day 30 and at 4 months using the PSEQ-10, a 10-item, valid and reliable tool to measure how confident a person feels to navigate recovery and persist in tasks despite the presence of pain.32 38 We will use the measurement taken at day 30 as our primary outcome for comparison. Low pain self-efficacy has been shown to be associated with higher levels of chronic pain32 39 and improvement in self-efficacy appears to mediate improvement in disability in response to treatment.40–42 The minimal clinically important difference (MCID) for the PSEQ has been estimated in several studies to fall between 5 and 6 points out of 60. In this study, we will consider a 5.5 or greater point difference between the two groups to be clinically important.43 44 The data collection plan for all outcomes can be seen in table 1. Table 1Data collection planProcedureDay 0Day 30Four monthsEligibility screening✓Informed consent✓Pain Self-Efficacy Questionnaire✓✓✓Oslo Social Support Scale (OSSS-3)✓Claims Satisfaction Questionnaire✓Pain-related distress (CAP-6)✓✓✓Pain and pain interference (PEG)✓✓✓Anxiety and depression (PHQ-4)✓✓✓Questions assessing reach and engagement with videos✓Healthcare costs (Allianz provided)✓Return to work times (Allianz provided)✓Feedback questions(acceptability and feedback)✓Extended feedback interview (10–15 participants)✓CAP-6, Concerns About Pain tool; PEG, pain, enjoyment of life, general activity tool; PHQ-4, Patient Health Questionnaire-4. Data collection plan CAP-6, Concerns About Pain tool; PEG, pain, enjoyment of life, general activity tool; PHQ-4, Patient Health Questionnaire-4. Secondary outcome measures Pain and pain interference: assessed on day 0, day 30 and 4 months using the PEG – pain, enjoyment of life, general activity tool. This three-item tool is derived from the Brief Pain Inventory and has been demonstrated to be valid and reliable. Initial validation studies reported internal consistency (Cronbach’s α) of 0.73 and 0.89 in two samples, and strong construct validity (correlations r = 0.60–0.95 with established pain and function measures).45 An MCID has been reported to be 1 point on these 10-point scales.46 Anxiety and depression: assessed on day 0, day 30 and 4 months using the Patient Health Questionnaire-4 (PHQ-4),47 a brief, valid and widely used screening tool that measures symptoms of anxiety and depression. The PHQ-4 combines the first two items of the PHQ-9 (PHQ-2 for depression) and the first two items of the generalised anxiety disorder (GAD)-7 (GAD-2 for anxiety). The PHQ-4 has demonstrated strong construct and criterion validity in population and clinical samples.48 While no established MCID values are available for these ultra-brief instruments, both have demonstrated responsiveness to change in intervention studies.49 50 Changes will therefore be interpreted using effect sizes and associations with other outcome measures rather than predefined MCID thresholds. Claims Satisfaction Questionnaire (adapted from CSQ-8):51 claimant satisfaction with the claims process will be assessed on day 30 using a modified version of the Client Satisfaction Questionnaire (CSQ-8).51 Adaptations were developed in consultation with consumers and stakeholders to ensure content validity within the compensable injury context. The original CSQ-8 is an eight-item instrument designed to evaluate satisfaction with healthcare and related services and has been widely used across clinical and service delivery contexts. It demonstrates high internal consistency (Cronbach’s α=0.83–0.93), good test–retest reliability and construct validity supported by strong correlations with measures of perceived benefit, service quality and therapeutic alliance.51–53 No published MCID is available for the CSQ-8 or its derivatives; however, mean scores have been shown to differentiate between service models of varying perceived quality. Therefore, changes in satisfaction will be interpreted descriptively, with higher scores indicating greater satisfaction and comparisons made between trial groups to evaluate relative differences in claimant experience. Healthcare costs and return to work data: data on healthcare costs and return to work status will be obtained from Allianz who will match the participant via first name and telephone number. Healthcare costs can be an indirect indicator of how confident, informed and supported a claimant may feel during their recovery.54 Adoption, engagement and reach: in line with the RE-AIM framework,36 we will measure the following: Adoption and engagement: this will be measured on day 30 via the following three questions: Did you view the videos? (Yes I watched both completely, Yes I watched them partially, No I didn’t watch them) How often did you read the text messages? (Never, Rarely, Sometimes, Often, Always) If you received text messages in addition to the videos, how often did you act on the advice of the text messages? (Never, Rarely, Sometimes, Often, Always) Reach: we will evaluate the reach of the intervention by comparing the number of potential participants who are offered the programme (via information provided by case managers) and the number of those who consent to participate. Participant satisfaction with the SMS support programme: will be evaluated on day 30 using three questions: How satisfied were you with the additional support provided in the text messages? (Rated 1–5) Would you recommend the SMS delivered additional support to other people who are making a claim with Allianz? (Rated 1–5) Do you have any more feedback on the program? (Open text response) Concerns about pain: we will measure how worried a person is about their pain at baseline, 30 days and 4 months. Pain-related worry is a predictor of poor outcomes following injury, including the development of chronic pain.55 56 We will use the 6-item Concerns About Pain tool (CAP-6), that has been shown to have good internal consistency (Cronbach’s α=0.89) and reliability (intraclass correlation coefficient=0.77).57 The MCID has been reported as 4.5.58 Perceived social support: we will measure how supported a participant feels at baseline. Perceived social support can influence a person’s confidence, motivation and emotional resilience, including how they manage pain, stress and the challenges of recovery after an accident or injury.59 The OSSS-3 (Oslo Social Support Scale, 3-item version) will be used to assess perceived social support at baseline.60 It is a validated brief instrument that has demonstrated acceptable structural validity and modest internal consistency (eg, Cronbach’s α=0.60–0.65) in population-based studies.60 61 Participant characteristics: demographic characteristics will be recorded at the beginning of the study (day 0). To reduce participant survey burden, we will obtain demographic and socioeconomic characteristics for participants from Allianz. These will include age, gender, employment status, fault status of the accident and place of usual residence (postcode only). Acceptability and feasibility: to evaluate the acceptability and feasibility of the intervention, we will conduct semi-structured interviews with 10–15 participants who have indicated a willingness to provide further feedback. The purpose of these interviews is to explore participants’ experiences of the SMS support service in relation to key implementation outcomes informed by the RE-AIM framework,36 37 including perceptions of accessibility (Reach), perceived impact (Effectiveness), uptake (Adoption), engagement with the intervention components (Implementation) and likelihood of continued use or recommendation (Maintenance). Interviews will be conducted via Zoom, audio-recorded with participant consent and transcribed using the Zoom automatic transcription function. Participants will be given the opportunity to review and edit their de-identified transcript prior to analysis. A semi-structured interview guide (see online supplemental appendix G) will be used to ensure consistency while allowing participants to elaborate on issues most relevant to their experience. Thematic analysis will be used to identify common patterns across the dataset, following Braun and Clarke’s six-step process.62 63 Coding will be performed inductively by two members of the research team using NVivo (Denver, Colorado, USA) software. Emergent themes will be interpreted in light of the RE-AIM dimensions to identify barriers and enablers to broader implementation. Assignment of interventions Allocation Participants will be enrolled and consented electronically through the REDCap (Research Electronic Data Capture, Vanderbilt University, Nashville, Tennessee, USA) platform.64 After completing baseline questionnaires, participants will be randomised in a 1:1 ratio to either the intervention group (educational videos+daily supportive text messages) or the active control group (educational videos only). Randomisation will be performed within REDCap using a pre-programmed randomisation table, generated before recruitment by an independent researcher who is not involved in participant enrolment, data collection or analysis. Blinding/masking This is a double-blind randomised controlled trial. Participants, Allianz case managers, data collectors and the study statistician will remain blinded to group allocation. Participants are informed in the PISCF that they will be randomly allocated to one of two digital support programmes, both designed to aid recovery after a road traffic-related injury. They are not told that one group receives additional supportive messages, to preserve masking. This limited disclosure of the between-group difference is consistent with ethical guidance for maintaining blinding integrity in behavioural and digital health interventions and does not involve deception, as both conditions provide genuine recovery support.65 66 Participants in both groups receive their allocated content entirely online via their mobile device, with minimal or no researcher contact. All outcome data are collected through REDCap. For statistical analysis, the dataset will include a group variable coded as ‘A’ or ‘B’; unblinding will occur only after all analyses comparing groups have been completed. Data collection and management Participants will complete all questionnaires developed and administered through REDCap at the time points specified in table 1. The survey links will be sent to participants via SMS. All questionnaires are self-administered online. Qualitative data will be collected from a subset of participants who consent to an optional follow-up interview conducted at the end of the SMS intervention period (approximately day 30). Interviews will be held via Zoom, audio-recorded, transcribed and imported into NVivo for qualitative analysis. Feasibility and process data (eg, number of messages delivered, withdrawals and technical issues) will be extracted directly from the REDCap system and the SMS delivery platform, Messagemedia. Data provided by Allianz, including healthcare utilisation, return-to-work status, accident fault status and limited demographic information (age, gender and postcode) will be securely transferred and linked using participants’ phone numbers before de-identification for analysis. Research data collected through the study, including survey responses and qualitative interview data, will be accessible only to authorised members of The University of Sydney research team. Allianz Insurance Australia will not have access to identifiable research data collected from participants. Administrative data provided by Allianz (eg, healthcare utilisation and return-to-work outcomes) will be transferred securely to the research team and linked for analysis prior to de-identification. Participation in the study, survey responses, interview responses and decisions regarding withdrawal from the study will not be disclosed to claims personnel and will have no impact on claim management or entitlement decisions. Statistical methods Sample size A total of 254 participants will be recruited to allow for up to 40% attrition and to ensure adequate statistical power for the primary analysis. This attrition estimate was informed by previous digital health intervention trials, which commonly report follow-up losses of 20%–40%, particularly where outcomes are collected remotely via online surveys and without face-to-face participant contact.28 Based on previous research using the 10-item PSEQ-10, a clinically meaningful difference of 5.5 points (on a 0–60 scale) is expected between groups, assuming a SD of 12. To detect this difference at day 30 with 80% power at a two-sided alpha=0.05, 76 participants per group (152 total) are required. Allowing for anticipated loss to follow-up yields the target total of 254 participants. An interim review will be undertaken after approximately 25% of participants have completed the day 30 questionnaire to re-estimate variance and attrition, confirming the adequacy of the planned sample size. Statistical analysis All analyses will be conducted on an intention-to-treat basis for all participants who are randomised. Participants who received all the messages and did not opt out during the 30 days will be included in the per protocol analysis. The primary outcome is PSEQ-10 scores at 30 days post-randomisation. Between-group comparisons will be performed using analysis of covariance (ANCOVA) adjusting for baseline PSEQ scores. Secondary outcomes, including claim satisfaction, pain, pain-related distress, anxiety and depression, healthcare costs and return-to-work status, will be analysed using t-tests or Mann-Whitney U tests for continuous data and χ2 or Fisher’s exact tests for categorical outcomes. For all outcomes, a two-sided p value <0.05 will be considered statistically significant. All statistical analyses will be conducted using SAS software (V.9.4, SAS Institute). Explorative analysis Exploratory analyses will examine potential moderators and mediators of treatment effects, including baseline psychological distress, pain severity, sex, age and injury type. Associations between engagement metrics (eg, survey responses to questions about engagement) and outcomes will also be explored. Qualitative analysis Qualitative data will be analysed thematically to explore participants’ experiences of the SMS support programme, including perceptions of acceptability, usefulness, engagement and suggestions for improvement. Interviews will be transcribed verbatim and coded using an inductive approach informed by the framework method. Data will then be organised and interpreted in relation to the dimensions of the RE-AIM framework to contextualise participants’ perspectives on intervention feasibility and scalability. Two researchers will independently code a subset of transcripts to enhance analytical rigour and develop a coding framework, which will then be applied to the remaining transcripts. NVivo software (V.15)67 will be used to assist data management and analysis. Themes will be refined through iterative discussion among the research team, and representative quotes will be selected to illustrate key findings. Trial monitoring Oversight of trial conduct, data integrity and participant safety will be undertaken by the chief investigator and the research team at The University of Sydney. The study team will review recruitment, withdrawals, protocol deviations, technical issues and any adverse events or participant concerns identified during the trial and will report any issues requiring review to The University of Sydney Human Research Ethics Committee. Ethics and dissemination This study has received ethical approval from The University of Sydney Human Research Ethics Committee (HREC; 2025/HE001079). The planned recruitment start date is 1 September 2026. At the time of submission, recruitment had not yet commenced. Findings from the trial will be disseminated through publication in peer-reviewed journals and presentations at national and international scientific meetings in the fields of pain management, rehabilitation and digital health. A plain-language summary of study results will be provided to participants who opt to receive it and shared with Allianz Insurance Australia, the study’s funding partner, for translation into practice and policy. Results will also be made available to relevant stakeholders, including healthcare providers, insurers and policy makers, to inform future service delivery and early-intervention programmes. Discussion This protocol describes a double-blind, randomised controlled trial designed to evaluate the efficacy, feasibility and acceptability of an SMS-based digital health intervention for people recovering from road-traffic-related injury. The trial will test whether a brief, low-cost programme of supportive text messages, delivered alongside educational videos, improves pain self-efficacy and related recovery outcomes compared with an active control condition providing access to the same educational videos alone. The intervention content was co-designed in a separate qualitative study (The University of Sydney HREC 2025/HE000543) involving former Allianz claimants who had experienced a motor vehicle-related injury and Allianz staff. In that study, participants contributed to the development and refinement of both the text message library and the educational videos, ensuring that the tone, timing and content were relevant, empathetic and aligned with real-world claimant experiences. Incorporating consumer perspectives in the design phase aimed to enhance the intervention’s acceptability, engagement and ecological validity. These principles that are central to effective digital health and implementation research.68–70 This trial is motivated by evidence that higher distress within compensation processes is associated with poorer recovery and return-to-work outcomes.15 71 Further evidence also suggests that limited understanding of the claims process is a considerable source of distress for claimants8–10 16 and that claimants who are provided with targeted claims information find this to be helpful.16 Despite the increasing adoption of digital tools in healthcare and insurance settings, there remains limited evidence about the effectiveness of structured SMS programmes in improving psychological and functional outcomes for compensable injury claimants. By embedding this trial within an insurer-delivered pathway, the study addresses both clinical and system-level barriers to recovery. The trial is structured according to the RE-AIM framework36 37 to ensure that evaluation extends beyond efficacy to include reach, adoption, implementation and maintenance—domains critical for understanding real-world impact and scalability. If found to be effective, this intervention could be seamlessly integrated within existing claims-management systems, offering a pragmatic and scalable strategy for improving recovery, engagement and satisfaction among injured claimants. Several limitations should be acknowledged. All outcomes are self-reported and collected online, which may introduce response bias and restrict participation to individuals with sufficient digital literacy. While the educational video provided to both groups functions as an ethical and informative control, it may provide benefits that attenuate between-group differences, potentially underestimating the unique contribution of the SMS component. Finally, the 12-week follow-up period may not capture long-term outcomes; however, it is adequate for assessing early changes in self-efficacy, distress and feasibility of delivery within insurer workflows. A further limitation is that post-traumatic stress symptoms are not specifically assessed. Consequently, it will not be possible to examine whether post-traumatic stress influenced recovery outcomes or modified the effects of the intervention, and the findings will be interpreted with this limitation in mind. Furthermore, usual customer care will not be formally measured and may vary between participants. Consequently, the potential influence of differences in case manager support or service facilitation on study outcomes cannot be directly examined and will need to be considered when interpreting the findings. Detailed clinical information, including injury severity, pre-existing pain conditions, pre-existing mental health conditions and baseline functional status, will also not be collected. Consequently, the potential influence of these factors on recovery outcomes and intervention effects cannot be directly examined and will also need to be considered when interpreting the findings. Finally, blinding integrity will not be formally assessed. Consequently, it will not be possible to determine whether participants correctly inferred their group allocation or whether this influenced self-reported outcomes. Despite these limitations, this study represents an important step toward evidence-based digital support for people recovering from transport-related injuries. If the co-designed intervention proves effective and feasible, it may offer a scalable, consumer-centred approach to improving recovery, reducing distress and enhancing claimant experience across Australian injury-compensation systems. Supplementary material Footnotes Funding: This work was supported by Allianz Insurance Australia. Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online (https://doi.org/10.1136/bmjopen-2026-121932). Provenance and peer review: Not commissioned; externally peer reviewed. Patient consent for publication: Not applicable. Patient and public involvement: Patients and/or the public were involved in the design, or conduct, or reporting, or dissemination plans of this research. Refer to the Methods section for further details. References Supplementary Materials